Related Experiment Video
Updated: Aug 5, 2026
09:10
siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Small-molecule autophagy modulators: Mechanisms, therapeutic potential, and development challenges in pathological
Yongya Wu1, Jiaxiang Luo1, Haolin Tang1
1State Key Laboratory of Biotherapy and Cancer Center, Innovation Center of Nursing Research, West China Hospital, Sichuan University, Chengdu 610041, China.
Fundamental Research
|August 1, 2026
Summary
Autophagy, a cellular recycling process, is crucial for metabolism and development. Dysregulation is linked to diseases like cancer and neurodegeneration, offering therapeutic targets for small molecules.
Area of Science:
- Cell Biology
- Molecular Biology
- Pharmacology
Background:
- Autophagy is a fundamental cellular process for degrading and recycling intracellular components.
- Its dysregulation is implicated in various diseases, including cancer, immune disorders, and neurodegenerative conditions.
- Autophagy modulation presents a promising therapeutic avenue for these pathologies.
Purpose of the Study:
- To review the molecular mechanisms and signaling pathways governing autophagy.
- To summarize the role of autophagy in diverse physiological and pathological states.
- To discuss the potential and challenges of autophagy-targeted therapies, particularly small-molecule interventions.
Main Methods:
- Literature review of current research on autophagy.
- Analysis of small-molecule drug discovery strategies for autophagy regulation.
- Examination of clinical applications and limitations of autophagy-modulating agents.
Main Results:
- Autophagy's complex regulatory network is increasingly understood.
- Small molecules targeting autophagy-related proteins show therapeutic promise but face challenges.
- Existing drugs exhibit limitations in efficacy, selectivity, pharmacokinetics, and toxicity.
Conclusions:
- Autophagy plays a vital role in health and disease, making it a key therapeutic target.
- Developing effective and safe small-molecule autophagy modulators remains a significant challenge.
- Further research into molecular mechanisms and drug development strategies is essential for successful autophagy-targeted therapies.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...